Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells.
about
Epigenetic control of HIV-1 post integration latency: implications for therapyImpact of Chromatin on HIV ReplicationOngoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory AgentsActivation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapyAdvancements in Developing Strategies for Sterilizing and Functional HIV Cures.Effect of suberoylanilide hydroxamic acid (SAHA) administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-infected indian rhesus macaques.HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure researchEx vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapy.Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro.Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1.HIV-1 Latency and Eradication: Past, Present and FutureAlveolar rhabdomyosarcoma: morphoproteomics and personalized tumor graft testing further define the biology of PAX3-FKHR(FOXO1) subtype and provide targeted therapeutic options.International AIDS Society global scientific strategy: towards an HIV cure 2016.HIV eradication: combinatorial approaches to activate latent viruses.Progress and challenges in the use of latent HIV-1 reactivating agentsToxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells.In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.Histone deacetylase inhibitors containing a benzamide functional group and a pyridyl cap are preferentially effective human immunodeficiency virus-1 latency-reversing agents in primary resting CD4+ T cells.Kinetics of HIV-1 Latency Reversal Quantified on the Single-Cell Level Using a Novel Flow-Based TechniqueAdministration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients.Histone deacetylase inhibitor romidepsin inhibits de novo HIV-1 infections.Proteomic Profiling of a Primary CD4+ T Cell Model of HIV-1 Latency Identifies Proteins Whose Differential Expression Correlates with Reactivation of Latent HIV-1.Maraviroc is associated with latent HIV-1 reactivation through NF-κB activation in resting CD4+ T cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
P2860
Q26781191-48562995-D57A-47F1-9701-F759BB0E348AQ26782046-968810E9-4DE0-4BDA-96F6-19AB8792EEF5Q28079455-D094F017-EFF6-4694-9D00-4F5306EF690FQ28544949-CF5B6921-FB5D-406E-9EF5-2CC60C99A030Q33654409-44D1E886-E01D-43E9-B4AA-2F34A6AE4F25Q34596417-8BAB12BD-FE77-4352-AF29-FA995D868CCEQ35009720-32532929-D43A-4110-AA93-F44C90C5D792Q35436367-744A3172-901E-48D2-944A-CBBC35836337Q36068841-0E8288CF-CD94-46C1-A215-D2C0F3ADFE3BQ36525896-86329F19-4C44-4B0E-81DD-FDB3061BE214Q37505823-A8666749-34A5-4C32-9B15-B727FB29497EQ37564708-FC11DD79-C435-4D8D-9849-BE2582E188AEQ37661770-1379CC90-8F19-42AF-AFA6-90F7CED2DB40Q38271132-4988E5D7-42D2-4C94-8994-25BAF5D875AEQ38509230-9694CD3A-7D25-45D6-BCDB-198F9C40E867Q38924992-2D5D399B-0D74-468E-8300-2B5EFD7D1649Q39749215-CD8D165B-293C-46FE-9826-BCA5D3E5F6E9Q40361855-08F95B65-31A6-4957-A452-610593F01256Q40597173-2399F3E9-6DD0-4964-AA61-49D9E5E1CAE9Q40860152-1F1AEA5E-7E91-4130-9345-55CD7C7F08F8Q41036069-D5E677DF-848F-42E6-B295-37C176208C7DQ47587530-43D512AC-0FF3-41A8-A748-903A61E7A808Q52695029-8289F211-2FFF-4101-9BDB-4C27B28F47BC
P2860
Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Entinostat is a histone deacet ...... ntly infected primary T cells.
@ast
Entinostat is a histone deacet ...... ntly infected primary T cells.
@en
type
label
Entinostat is a histone deacet ...... ntly infected primary T cells.
@ast
Entinostat is a histone deacet ...... ntly infected primary T cells.
@en
prefLabel
Entinostat is a histone deacet ...... ntly infected primary T cells.
@ast
Entinostat is a histone deacet ...... ntly infected primary T cells.
@en
P2093
P2860
P50
P1433
P1476
Entinostat is a histone deacet ...... ently infected primary T cells
@en
P2093
Ajantha E Solomon
Andrew N Harman
Melissa Churchill
Suha Saleh
P2860
P304
P356
10.1097/QAD.0000000000000067
P407
P577
2013-11-01T00:00:00Z